Carregant...
Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information
Precision or personalized medicine is currently gaining a lot of attention. Clinical evidence for its effectiveness has been established based on randomized clinical trials accounting for classical risk factors, such as hypertension, diabetes, and serum lipids. However, besides such classical risk f...
Guardat en:
| Publicat a: | J Atheroscler Thromb |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Japan Atherosclerosis Society
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8147010/ https://ncbi.nlm.nih.gov/pubmed/33229815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.60087 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|